Tong Xiao

USPTO Granted Patents = 14 (Patent Applications = 5)

CIPO Patents = 4

EPO Patents = 2 (Patent Applications = 11)

Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 18(Granted Patents)

Company Filing History:

10 out of 2,077

Janssen Pharmaceutica Nv

patents

3 out of 16

Baruch S. Blumberg Institute

Arbutus Biopharma Corporation

patents

5. 1 out of 52

Philadelphia Health and Education Corporation

patents

6. 1 out of 1

Enantigen Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2006-2018

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9938236 - Antiviral agents against HBV infection (2018-04-10),

2. 9533990 - Inhibitors of secretion of hepatitis B virus antigens (2017-01-03),

3. 9359327 - Process for the preparation of substituted pyrimidine derivatives (2016-06-07),

4. 9079884 - Process for the preparation of substituted pyrimidine derivatives (2015-07-14),

5. 9079883 - Process for the preparation of substituted pyrimidine derivatives (2015-07-14),

6. 9079882 - Process for the preparation of substituted pyrimidine derivatives (2015-07-14),

7. 8921381 - Inhibitors of secretion of hepatitis B virus antigens (2014-12-30),

8. 8835633 - Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives (2014-09-16),

9. 8309720 - Process for the preparation of substituted pyrimidine derivatives (2012-11-13),

10. 8168829 - Synthesis of quaternary salt compounds (2012-05-01),

11. 8063206 - Processes for the preparation of cyclopropyl-amide derivatives (2011-11-22),

12. 7795426 - Processes for the preparation of cyclopropyl-amide derivatives (2010-09-14),

13. 7728129 - Processes for the preparation of piperazinyl and diazapanyl benzamide derivatives (2010-06-01),

14. 6992189 - Synthesis of piperidine and piperazine compounds as CCR5 antagonists (2006-01-31),

Title: The Innovative Contributions of Tong Xiao

Introduction

Tong Xiao is a prominent inventor based in Edison, NJ (US), known for his significant contributions to the field of antiviral research. With a total of 14 patents to his name, he has made remarkable strides in developing novel compounds aimed at combating viral infections, particularly those related to Hepatitis B virus (HBV).

Latest Patents

Among his latest patents, one notable invention focuses on antiviral agents against HBV infection. This invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds are useful as nucleocapsid assembly inhibitors. In other embodiments, these compounds serve as pregenomic RNA encapsidation inhibitors of Hepatitis B virus. Additionally, his work includes inhibitors of secretion of hepatitis B virus antigens, where pharmaceutical compositions comprise triazolopyrimidines useful for treating hepatitis virus in patients.

Career Highlights

Throughout his career, Tong Xiao has worked with esteemed organizations such as Janssen Pharmaceutica NV and the Baruch S. Blumberg Institute. His innovative research has contributed to advancements in the treatment of viral infections, showcasing his dedication to improving public health.

Collaborations

Tong has collaborated with notable professionals in his field, including David C. Palmer and Sergio Cesco-Cancian. These partnerships have further enhanced the impact of his research and inventions.

Conclusion

Tong Xiao's work exemplifies the spirit of innovation in the fight against viral infections. His contributions through patents and collaborations continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.